Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.58 |
| ▸ | IGF1R | P08069 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11552206 | 1.00 | CALM1 (0.58) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL11401615 | 1.00 | CALM1 (0.58) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL5045835 | 0.98 | CALM1 (0.60) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL5168832 | 0.92 | CALM1 (0.62) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL7549717 | 0.90 | CALM1 (0.60) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL17400406 | 0.89 | CALM1 (0.69) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL11007798 | 0.89 | CALM1 (0.69) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL9509173 | 0.89 | CALM1 (0.69) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL10571532 | 0.89 | CALM1 (0.69) | CALM1IGF1RALOX15TDP1L3MBTL1 | |
| SCHEMBL4254058 | 0.87 | CALM1 (0.72) | CALM1IGF1RALOX15TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5656636-A | TREATING PSORIASIS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-08-12 | — | — | US | disclosed |
| US-5633258-A | Pyridine compounds for treating leukotriene-related diseases | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5631262-A | Pyridine compounds for treating leukotriene-related diseases | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0675718-A1 | SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS LEUKOTRIENE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-11 | — | — | EP | disclosed |
| EP-0675718-A4 | SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS LEUKOTRIENE ANTAGONISTS. | SMITHKLINE BEECHAM CORP (US) | 1995-08-22 | — | — | EP | disclosed |
| EP-0639975-A1 | HETEROCYCLIC-SUBSTITUTED PYRIDINE COMPOUNDS AND USES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-03-01 | — | — | EP | disclosed |
| EP-0639975-A4 | HETEROCYCLIC-SUBSTITUTED PYRIDINE COMPOUNDS AND USES. | SMITHKLINE BEECHAM CORP (US) | 1994-10-24 | — | — | EP | disclosed |
| CN-1092409-A | The compound that is used for the treatment of leukotriene-related disease | SMITHKLINE BEECHAM CORP (US) | 1994-09-21 | — | — | CN | disclosed |
| WO-1994014442-A1 | SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS LEUKOTRIENE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-07 | — | — | WO | disclosed |
| EP-0604529-A1 | PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0593464-A1 | BENZOIC ACID DERIVATIVES and their use as LTB4 inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1994-04-27 | — | — | EP | disclosed |
| WO-1993022285-A1 | LEUKOTRIENE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-11-11 | — | — | WO | disclosed |
| WO-1993011768-A1 | PYRIDYL COMPOUNDS FOR PSORIASIS TREATMENT | SMITHKLINE BEECHAM CORPORATION (US) | 1993-06-24 | — | — | WO | disclosed |
| CN-1073431-A | The compound that is used for the treatment of leukotriene-related disease | SMITHRLINE BEECHAM CORP (US) | 1993-06-23 | — | — | CN | disclosed |
| WO-1993010780-A1 | HETEROCYCLIC-SUBSTITUTED PYRIDINE COMPOUNDS AND USES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-06-10 | — | — | WO | disclosed |
| WO-1993006085-A1 | PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0593464-A4 | BENZOIC ACID DERIVATIVES. | SMITHKLINE BEECHAM CORP (US) | 1993-02-12 | — | — | EP | disclosed |
| WO-1991018601-A1 | BENZOIC ACID DERIVATIVES | SMITHKLINE BEECHAM CORPORATION (US) | 1991-12-12 | — | — | WO | disclosed |